Molecular biology for the radiation oncologist: the 5Rs of radiobiology meet the hallmarks of cancer.
Recent advances in our understanding of the biology of cancer have provided enormous opportunities for the development of novel therapies against specific molecular targets. It is likely that most of these targeted therapies will have only modest single agent activities but may have the potential to accentuate the therapeutic effects of ionising radiation. In this introductory review, the 5Rs of classical radiobiology are interpreted in terms of their relationship to the hallmarks of cancer. Future articles will focus on the specific hallmarks of cancer and will highlight the opportunities that exist for designing new combination treatment regimens.
Harrington
K
K
The Institute of Cancer Research, Targeted Therapy Laboratory, Cancer Research UK, Centre for Cell and Molecular Biology, London, UK. kevinh@icr.ac.uk
Jankowska
P
P
Hingorani
M
M
D000970:Antineoplastic Agents; D017209:Apoptosis; D015195:Drug Design; D006801:Humans; D008967:Molecular Biology; D009369:Neoplasms / Q000532:radiotherapy*; D018787:Radiation Oncology; D011853:Radiobiology; D011878:Radiotherapy; D015398:Signal Transduction
D000970:Antineoplastic Agents